Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access CenterGlobeNewsWire • 06/07/23
Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their StudiesGlobeNewsWire • 06/01/23
Seer's Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progressionGlobeNewsWire • 03/29/23
Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 OutlookGlobeNewsWire • 03/02/23
Down -26.63% in 4 Weeks, Here's Why You Should You Buy the Dip in Seer, Inc. (SEER)Zacks Investment Research • 02/27/23
Seer, Inc. (SEER) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 02/23/23
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023GlobeNewsWire • 02/09/23
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERSPRNewsWire • 12/14/22
Seer's Proteomics Platform Named as Top 10 Innovation in 2022 by The ScientistGlobeNewsWire • 12/12/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/09/22